Form 4 for NTRA Natera, Inc.

Accepted 2024-10-23 00:00:00 ET · period of report 2024-10-21 · accession 0001415889-24-025598 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-10-23	2024-10-21+	NTRA	Moshkevich Solomon	Pres, CLINICALDIAGNOSTICS	S - Sale	$120.44	-550	112.1K	-0.5%	-$66.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-10-22	S	D	256	$120.07	111,891	D	—	—	(F3) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021.
2	Common	Common Stock	2024-10-21	S	D	294	$120.76	112,147	D	—	—	(F1) The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 28, 2022. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.6750 to $120.7600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.